Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lyell Immunopharma Inc (NQ: LYEL )

3.400 -0.080 (-2.30%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 567,437
Open 3.400
Bid (Size) 3.260 (5)
Ask (Size) 3.870 (1)
Prev. Close 3.480
Today's Range 3.370 - 3.550
52wk Range 2.740 - 8.740
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Lyell Immunopharma to Participate in 41st Annual J.P. Morgan Healthcare Conference
From Lyell Immunopharma, Inc
Via Globe NewsWire

Performance

YTD
+1.19%
+1.19%
1 Month
-5.03%
-5.03%
3 Month
-40.14%
-40.14%
6 Month
-53.23%
-53.23%
1 Year
-40.04%
-40.04%

More News

Read More
Lyell Immunopharma Appoints Lynn Seely, MD as President and Chief Executive Officer
From Lyell Immunopharma, Inc
Via Globe NewsWire
Lululemon, Li Auto, Hackett Group And Some Other Big Stocks Moving Lower On Friday
Via Benzinga
GSK Walks Away From T-Cell Therapy Pact With Lyell Citing Strategic Actions
Via Benzinga
Analyst Sees A Leader In Solid Tumor Cell Therapy In This Stock
Via Benzinga
Lyell Immunopharma to Participate in BofA Securities Biotech Conference
From Lyell Immunopharma, Inc
Via Globe NewsWire
Lyell Immunopharma to Participate in Barclays Virtual Fireside Chat Series
From Lyell Immunopharma, Inc
Via Globe NewsWire
Lyell Immunopharma Reports Recent Business Highlights and Third Quarter Financial Results
From Lyell Immunopharma, Inc
Via Globe NewsWire
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday
Via Benzinga
Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Lyell Immunopharma Presents New Data at SITC Highlighting its Growing Pipeline of T – Cell Reprogramming Technologies and Product Candidates Targeting Solid Tumors
From Lyell Immunopharma, Inc
Via Globe NewsWire
Lyell Immunopharma to Participate in Credit Suisse Healthcare Conference
From Lyell Immunopharma, Inc
Via Globe NewsWire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
5 Value Stocks In The Healthcare Sector
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2022
Via Benzinga
Lyell Immunopharma Announces FDA Clearance of its IND for LYL845, a TIL Product Candidate Enhanced with its Novel Epigenetic Reprogramming Technology for Solid Tumors
From Lyell Immunopharma, Inc
Via Globe NewsWire
Lyell Immunopharma to Present Preclinical Data Highlighting New T-Cell Reprogramming Technologies and its Growing Pipeline at 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting
From Lyell Immunopharma, Inc
Via Globe NewsWire
Lyell Immunopharma Announces the Appointment of Rahsaan Thompson as Chief Legal Officer
From Lyell Immunopharma, Inc
Via Globe NewsWire
5 Value Stocks In The Healthcare Sector
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why U.S. Stocks Are Trading Lower; AZZ Earnings And More
Via Benzinga
Biotech ETF Tops in June: 5 Stocks That Outperform
Via Talk Markets
89 Biggest Movers From Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.